[cnbc 3000093946]
Daniel Junius, ImmunoGen chairman/CEO, discusses the latest developments in therapeutics for the treatment of cancer.
With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.
Video © and provided by CNBC.
Be the first to comment